By suppressing the TGF-β-Smad-ASCL1 pathway, EZH2 overexpression constricted transforming growth factor-beta (TGF-β)-mediated apoptosis and promoted the progression of small cell lung cancer.78 The gene discussed is EZH2; the disease is small cell lung carcinoma.